8 reports

  • MAY 17, 2017: NEW RESEARCH PUBLISHED ON INVESTIGATIONAL ANTIMALARIAL DRUG
  • Research and Development Brief
  • Antimalarials
  • Research And Development
  • United States
  • Product Initiative
  • Sanaria Inc.
  • ANTIMALARIAL ACTIVITY. ADDITIONAL DATA WILL DEMONSTRATE ACTIVITY AGAINST MYCOBACTERIUM LEPRAE.
  • SEP 21, 2016: NOVEL NOVARTIS MALARIA COMPOUND SHOWS POTENTIAL TO BE EFFECTIVE AGAINST INFECTIONS RESISTANT TO ALL CURRENTLY AVAILABLE ANTIMALARIAL DRUGS
  • Antimalarials
  • Research And Development
  • United States
  • World
  • Product Initiative

Treatment includes antimalarial, antiseizure and anti inflammatory medications.

  • Antimalarials
  • Malaria
  • World
  • Product Initiative
  • Eisai Co., Ltd.

In August 2012, DesignMedix, Inc was awarded a Phase I SBIR fund of USD ##, ## from National Institute of Allergy and Infectious Diseases (NIAID) (NIH No. ##R##AI##-##) for the project entitled " optimization of a novel antimalarial drug candidate for plant-scale synthesis".

  • Antimalarials
  • United States
  • World
  • Product Initiative
  • DesignMedix
  • Clinical Trial profile. 815 Trial Title
  • Clinical Trial profile. 400 Trial Title
  • Antimalarials
  • Clinical Trial
  • Malaria
  • World
  • GlaxoSmithKline plc

This is in contrast to the majority of antimalarial drugs, whose action is limited to shorter stages of Plasmodium' s life cycle.

  • Antimalarials
  • Malaria
  • World
  • Product Initiative
  • Domainex Ltd

Artemether is an antimalarial agent and it also elicits anti-neoplastic effects.

  • Antimalarials
  • Therapy
  • World
  • Product Initiative
  • LondonPharma Ltd

IN CERTAIN DEVELOPING COUNTRIES, COUNTERFEIT MEDICINES ARE AVAILABLE FOR ALMOST ALL DISEASES, RANGING FROM CHILDREN' S COUGH SYRUP TO ANTIMALARIAL DRUGS.

  • Antimalarials
  • United States
  • Merck & Co., Inc.
  • Mylan Inc.
  • Pfizer Inc.